For example, an open-label RCT (N = 89), the partial 5-HT1A agonist buspirone, administered as an adjunct to escitalopram for eight weeks, demonstrated improved working memory in MDD compared with escitalopram monotherapy [53]. This evidence concerns the gene HTR1A and major depressive disorder.